JENNIFER MILLER: Open Payments
NPI 1730850835 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,776 in 108 payments from 18 companies in 2025. Trend: 2023 $2,541 · 2024 $1,685 · 2025 $2,776
Food & beverage: $2,692Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $934 |
| Janssen Biotech, Inc. | 14 | $417 |
| Phathom Pharmaceuticals, Inc. | 7 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $256 |
| Braintree Laboratories, Inc. | 3 | $119 |
| Ipsen Biopharmaceuticals, Inc | 4 | $111 |
| Lilly USA, LLC | 4 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| Aimmune Therapeutics, Inc. | 4 | $69 |
Products named: RINVOQ, TREMFYA, VOQUEZNA, SKYRIZI, SUFLAVE, DUPIXENT, IQIRVO, ENTYVIO.
Industry payments across TX — which companies pay providers there.
